Recombinant flagellin vaccines
CA 1340817 C · Owner: The Board Of Trustees Of The Leland Stanford Junior University · Inventors: Newton, Salete Maria Cardozo; Stocker, Bruce Arnold Dunbar; Majarian, William Robert
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to, recombinant genes and their encoded proteins which are recombinant flagellin fusion proteins. Such fusion proteins comprise amino acid sequences specifying an epitope encoded by a flagellin structural gene and an epitope of a heterologous organism which is immunogenic upon introduction of the fusion protein into a vertebrate host. The recombinant genes and proteins of the present invention can be used in vaccine formulations, to provide protection against infection by the heterologous organism or to provide, protection against conditions or disorders caused by an antigen of the organism. In a specific embodiment attenuated invasive bacteria expressing …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted November 9, 1999. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended November 9, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.